Skip to main content
Caplight Logo









Precision Neuroscience

Precision Neuroscience

Private
New York City, New YorkHealthcare & Life Scienceshttps://precisionneuro.io/

Last Round

Series D

Sep 24, 2026

Est. Valuation

$520M

Total Funding Raised

$405M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Precision Neuroscience is a neurotechnology company that develops minimally invasive brain-computer interface technology aimed at delivering effective treatments for patients with neurological disorders by facilitating direct connections between the human brain and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

brain-computer interfaceBCIbrain chipneural implantminimally invasive BCIneural signal processingcortical interfaceneural decodingmedical deviceneurotechnologybrain-machine interfaceBMIneural engineeringbioelectronicsneural interface

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Precision Neuroscience Comparables

Compare Precision Neuroscience with similar companies based on industry and business-model similarity.

Precision Neuroscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tether
85%
Synchron
84%
Paradromics
82%

Precision Neuroscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DSep 24, 2026
VC RoundNov 5, 2025
Series CDec 16, 2024
Series BJan 25, 2023
Series AMay 25, 2021

Secondary Market Activity

Bids, offers, and trades by month

Data table
OperationDatePriceSizeShare ClassStructure
OFFER

Key People

Founding team and executive leadership

Benjamin Rapoport

Co-Founder And Chief Science Officer

Founding Team

Michael Mager

Co-Founder and Chief Executive Officer

Founding Team

Craig Mermel

President and Chief AI and Data Officer

Executive Team

Nathan Pletcher

Chief Technology Officer

Executive Team

Precision Neuroscience Investors

Notable investors and investment history

Precision Neuroscience investors
InvestorRounds
Forepont Capital PartnersSeries B
Steadview CapitalSeries B, Series C, Series A
SCI VenturesVC Round
Korea Investment PartnersSeries D
HV FundSeries D
B Capital GroupSeries B, Series C, Series D, Series A
JSL Health CapitalSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 24, 2026

    $250M round with participation from ARK Investment Management and Mubadala Capital.

  • Jun 16, 2026

    Monthly visitors increased 81% MoM, reaching 23K.

Recent news

Latest coverage and updates

  • is_developingSep 24, 2026

    Precisionneuro is developing neurosurgical system on Jan 1st '26.

  • receives_financingSep 24, 2026

    Precisionneuro received financing of $250M in Series D on Sep 24th '26.

  • hiresJul 23, 2026

    Precisionneuro hired John Donoghue as Scientific Advisor on Jul 23rd '26.

  • launchesJul 22, 2026

    Precisionneuro launched Layer 7 brain-computer interface on Jul 21st '26.

Precision Neuroscience Filings

Explore SEC and related filing metadata, where available.

Precision Neuroscience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Precision Neuroscience's valuation, stock price, and market status.

Is Precision Neuroscience a public or private company?

Precision Neuroscience is a private company.

What is the current stock price of Precision Neuroscience?

Precision Neuroscience is a private company with no public stock price. No recent secondary market data is available.

How much is Precision Neuroscience worth (valuation)?

Precision Neuroscience's valuation is estimated at $500.0M based on funding round data.

Can I buy Precision Neuroscience stock?

Precision Neuroscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Precision Neuroscience's last funding round?

Precision Neuroscience's most recent funding round was VC Round on December 16, 2024.

Who are the main investors in Precision Neuroscience?

Key investors in Precision Neuroscience include Forepont Capital Partners, Steadview Capital, SCI Ventures, B Capital Group, General Equity Holdings.

Will Precision Neuroscience IPO soon?

No public IPO plans have been announced for Precision Neuroscience.

How can I track Precision Neuroscience secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Precision Neuroscience's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range115
Year Founded2021
Last FundingSep 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?